BBBT: AI 评分 44/100 — AI 分析 (4月 2026)

Black Bird Biotech, Inc. operates in the biotech sector, focusing on biopesticides and CBD products. The company's MiteXstream targets spider mites, while its Grizzly Creek Naturals brand offers CBD-infused products.

Key Facts: AI Score: 44/100 Sector: Healthcare

公司概况

概要：

Black Bird Biotech, Inc. is a biotech company specializing in plant-based biopesticides and CBD products, including MiteXstream for spider mite eradication and the Grizzly Creek Naturals line of CBD oils and personal care items. The company also engages in industrial hemp cultivation under the Montana Hemp pilot program.

BBBT是做什么的？

Black Bird Biotech, Inc., formerly known as Digital Development Partners, Inc., was rebranded in June 2021 to reflect its focus on biotechnology. The company develops, manufactures, and distributes a range of products, including MiteXstream, a plant-based biopesticide designed to eradicate spider mites, a common pest in agriculture and horticulture. This product represents a key offering in the company's portfolio, targeting the agricultural sector's need for environmentally friendly pest control solutions. In addition to its biopesticide products, Black Bird Biotech also manufactures and sells CBD-infused products under the Grizzly Creek Naturals brand. This line includes CBD oils, gummies, pet treats, and personal care products, catering to the growing market for CBD-based wellness solutions. The company also produces hand sanitizer gel and spray products. Furthermore, Black Bird Biotech participates in the Montana Hemp pilot program, growing industrial hemp for various applications. Based in Flower Mound, Texas, the company aims to leverage its biotech expertise to develop and market innovative products in both the agricultural and consumer wellness sectors. The company's evolution reflects a strategic shift towards biotechnology and a commitment to developing plant-based solutions.

BBBT的投资论点是什么？

Black Bird Biotech, Inc. presents a high-risk, high-reward investment opportunity given its early stage and OTC market listing. The company's focus on MiteXstream, a plant-based biopesticide, addresses a growing demand for sustainable agricultural solutions. However, the company's negative profit margin of -2009.1% and gross margin of -67.7% indicate significant financial challenges. Future growth hinges on successful market penetration of MiteXstream and expansion of the Grizzly Creek Naturals CBD product line. The company's small size and limited resources, managing with only 4 employees, pose operational risks. Investors should closely monitor revenue growth, cost management, and regulatory developments in the biopesticide and CBD markets. The company's beta of 2.01 suggests high volatility.

BBBT在哪个行业运营？

Black Bird Biotech operates within the specialty and generic drug manufacturing industry, which is experiencing growth driven by increasing demand for biopesticides and CBD products. The market for biopesticides is expanding as farmers seek sustainable alternatives to traditional chemical pesticides. The CBD market is also growing, fueled by increasing consumer awareness of the potential health benefits of CBD. However, the industry is highly competitive, with established players and new entrants vying for market share. Black Bird Biotech faces competition from larger companies with greater resources and established distribution networks. The company's success depends on its ability to differentiate its products and effectively market them to target customers.

Drug Manufacturers - Specialty & Generic

Healthcare

BBBT有哪些增长机遇？

Expansion of MiteXstream Market: The market for biopesticides is projected to grow as environmental regulations tighten and consumer demand for organic produce increases. Black Bird Biotech can capitalize on this trend by expanding the distribution of MiteXstream to new geographic markets and crops. The company can also invest in research and development to improve the efficacy of MiteXstream and develop new biopesticide products. The global biopesticides market is estimated to reach billions of dollars, providing a significant growth opportunity for Black Bird Biotech.
Growth of Grizzly Creek Naturals CBD Product Line: The CBD market is experiencing rapid growth, driven by increasing consumer awareness of the potential health benefits of CBD. Black Bird Biotech can expand its Grizzly Creek Naturals product line by introducing new CBD-infused products, such as topicals, edibles, and beverages. The company can also expand its distribution channels by partnering with retailers and online marketplaces. The global CBD market is projected to reach billions of dollars, offering a substantial growth opportunity for Black Bird Biotech.
Strategic Partnerships: Black Bird Biotech can pursue strategic partnerships with agricultural companies, retailers, and other businesses to expand its market reach and product offerings. For example, the company could partner with an agricultural company to distribute MiteXstream to its customers or with a retailer to sell Grizzly Creek Naturals products in its stores. Strategic partnerships can provide Black Bird Biotech with access to new markets, customers, and resources.
Industrial Hemp Cultivation Expansion: Black Bird Biotech's participation in the Montana Hemp pilot program provides an opportunity to expand its industrial hemp cultivation operations. Industrial hemp can be used to produce a variety of products, including textiles, building materials, and biofuels. Black Bird Biotech can increase its revenue by growing and selling industrial hemp to manufacturers. The market for industrial hemp is growing, driven by increasing demand for sustainable and environmentally friendly products.
Regulatory Approvals for New Products: Obtaining regulatory approvals for new biopesticide and CBD products can provide Black Bird Biotech with a competitive advantage. Regulatory approvals can demonstrate the safety and efficacy of the company's products, making them more attractive to customers. Black Bird Biotech can invest in research and development to develop new products that meet regulatory requirements. Successfully navigating the regulatory landscape can open doors to new markets and revenue streams.

Market Cap of $0.00B indicates a micro-cap company with limited financial resources.
P/E Ratio of -0.02 reflects negative earnings and challenges in achieving profitability.
Profit Margin of -2009.1% highlights significant losses relative to revenue.
Gross Margin of -67.7% suggests that the cost of goods sold exceeds revenue, indicating pricing or production inefficiencies.
Beta of 2.01 indicates higher volatility compared to the market, suggesting a riskier investment.

BBBT提供哪些产品和服务？

Manufactures and distributes MiteXstream, a plant-based biopesticide.
Sells CBD oils, gummies, and pet treats under the Grizzly Creek Naturals brand.
Offers CBD-infused personal care products.
Produces hand sanitizer gel and spray products.
Grows industrial hemp under the Montana Hemp pilot program.
Develops biotech products for agricultural and consumer markets.

BBBT如何赚钱？

Revenue from the sale of MiteXstream biopesticide to agricultural customers.
Sales of Grizzly Creek Naturals CBD products through retail and online channels.
Income from the cultivation and sale of industrial hemp.
Potential revenue from licensing or partnering on its biotech products.

Farmers and agricultural businesses seeking biopesticide solutions.
Consumers interested in CBD-based wellness products.
Retailers and distributors of agricultural and consumer products.
Manufacturers who use industrial hemp as a raw material.

Proprietary plant-based biopesticide formulation for MiteXstream.
Established brand recognition for Grizzly Creek Naturals in the CBD market.
Participation in the Montana Hemp pilot program providing access to hemp cultivation.
Focus on sustainable and environmentally friendly products appealing to conscious consumers.

什么因素可能推动BBBT股价上涨？

Upcoming: Potential regulatory approvals for new biopesticide or CBD products.
Ongoing: Expansion of distribution channels for MiteXstream and Grizzly Creek Naturals.
Ongoing: Increasing consumer demand for sustainable agricultural solutions and CBD products.

BBBT的主要风险是什么？

Potential: Competition from larger companies with greater resources.
Potential: Regulatory changes in the biopesticide and CBD markets.
Ongoing: Negative profit and gross margins.
Ongoing: Limited financial resources.
Ongoing: OTC market listing.

BBBT的核心优势是什么？

Proprietary plant-based biopesticide (MiteXstream).
Established CBD brand (Grizzly Creek Naturals).
Participation in Montana Hemp pilot program.
Focus on sustainable and environmentally friendly products.

BBBT的劣势是什么？

Negative profit and gross margins.
Limited financial resources.
Small number of employees (4).
OTC market listing.

BBBT有哪些机遇？

Expanding biopesticide market.
Growing CBD market.
Strategic partnerships.
Industrial hemp cultivation expansion.

BBBT面临哪些威胁？

Competition from larger companies.
Regulatory changes in the biopesticide and CBD markets.
Fluctuations in commodity prices (hemp).
Economic downturn affecting consumer spending.

BBBT的竞争对手是谁？

Advantage Solutions, Inc. — Provides sales and marketing solutions, potentially overlapping in distribution channels. — (ADVT)
Can-Fite BioPharma Ltd. — Focuses on pharmaceutical development, differing in product focus but competing for investment. — (CANL)
EAP Innovations, Inc. — Unknown differentiation due to lack of available information. — (EAPH)
Graphene Composites Ltd. — Materials science company, dissimilar business model. — (GCAN)
Greenrose Holding Company Inc. — Cannabis company, competing in the CBD market. — (GREH)

Key Metrics

MoonshotScore: 44/100

Company Profile

CEO: Nelson Grist
Headquarters: Argyle, US
Employees: 4
Founded: 2009

AI Insight

AI analysis pending for BBBT

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does Black Bird Biotech, Inc. do?

Black Bird Biotech, Inc. is a biotech company focused on developing and marketing plant-based solutions for the agricultural and consumer wellness markets. Its primary product is MiteXstream, a biopesticide designed to eradicate spider mites in crops. Additionally, the company manufactures and sells CBD-infused products under the Grizzly Creek Naturals brand, including oils, gummies, and personal care items. Black Bird Biotech also participates in the Montana Hemp pilot program, cultivating industrial hemp. The company aims to provide sustainable and environmentally friendly alternatives to traditional chemical pesticides and wellness products.

What do analysts say about BBBT stock?

As of 2026-03-17, there is no available analyst coverage for Black Bird Biotech, Inc. due to its OTC listing and small market capitalization. Key valuation metrics such as price-to-earnings (P/E) ratio and price-to-sales (P/S) ratio are not meaningful due to the company's negative earnings and limited revenue. Investors should conduct their own thorough research and consider the company's financial challenges, growth opportunities, and risks before making any investment decisions. The company's future performance will depend on its ability to improve profitability and expand its market share.

What are the main risks for BBBT?

Black Bird Biotech, Inc. faces several significant risks, including intense competition from larger companies with greater resources, potential regulatory changes in the biopesticide and CBD markets, and the company's negative profit and gross margins. Its limited financial resources and small number of employees pose operational challenges. The company's OTC market listing also carries risks associated with lower liquidity, higher volatility, and limited financial disclosure. Investors should carefully consider these risks before investing in Black Bird Biotech, Inc.